Tandem Diabetes Care Faces Multiple Downgrades

Tandem Diabetes Care shares are trading lower following a series of downgrades from several firms. Piper Sandler downgraded its price target to $14.00, RBC to $25.00, TD Cowen to $20.00, Jefferies to $45.00, and Leerink Partners to $32.00.